Correspondence 0001628280-24-023517 from Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc.
Date: May 15, 2024 · CIK: 0001830214 · Accession: 0001628280-24-023517
AI Filing Summary & Sentiment
File numbers found in text: 333-279280
Show Raw Text
CORRESP 1 filename1.htm Document Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue 8th Floor Boston, MA 02210 May 15, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tim Buchmiller Re: Ginkgo Bioworks Holdings, Inc. Registration Statement on Form S-3 (File No. 333-279280) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 17, 2024, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact Marko Zatylny (marko.zatylny@ropesgray.com) / telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, GINKGO BIOWORKS HOLDINGS, INC. By: /s/ Mark Dmytruk Name: Mark Dmytruk Title: Chief Financial Officer [Signature Page to Acceleration Request]